Duration of “Good On” time per dose: Immediate-release carbidopa-levodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT®)

R. A. Hauser, H. H. Fernandez, J. Jimenez-Shahed, S. Allard, G. Banisadr, S. Fisher, R. D'Souza

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Duration of “Good On” time per dose: Immediate-release carbidopa-levodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT®)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science